
Alzamend Neuro Introduces Reverse Stock Split
Alzamend Neuro, Inc. (Nasdaq: ALZN), a clinical-stage biopharmaceutical company specializing in treatments for Alzheimer’s disease (AD), bipolar disorder (BD), major depressive disorder (MDD), and post-traumatic stress disorder (PTSD), has announced a one-for-ten reverse stock split of its common stock. The…











